📰 Hyperfine Inc News
Page 3 - Hyperfine Inc News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Hyperfine Inc. Real-time updates on events, politics, business and more.
October 12, 2023
Advanced artificial intelligence (AI) algorithms are now integrated across all Swoop® ultra-low-field brain imaging system sequences
October 9, 2023
GUILFORD, Conn., October 09, 2023--Hyperfine, Inc. receives FDA clearance for updated AI-powered software with improved image quality for all Swoop® system sequences
October 9, 2023
09.10.2023 - Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking medical device company that has redefined brain imaging with the world’s first FDA-cleared portable magnetic resonance brain imaging system—the Swoop system—today announced FDA clearance of updated ... Seite 1
August 17, 2023
/PRNewswire/ -- The "Pediatric MRI Market Forecast to 2028 by Type, Application, Product Type, Age Group, End-user, and Region" report has been added to...
August 9, 2023
Multi-site observational study seeks to redefine the standard of care for pediatric hydrocephalus management ...
August 9, 2023
Hyperfine, Inc. announced completed enrollment for the multi-site observational study, HOPE PMR . Children living with hydrocephalus typically undergo at least two brain scans per year to monitor...
August 9, 2023
Multi-site observational study seeks to redefine the standard of care for pediatric hydrocephalus management
August 7, 2023
Hyperfine (NASDAQ:HYPR – Get Free Report) and CONMED (NYSE:CNMD – Get Free Report) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their earnings, valuation, risk, institutional ownership, dividends, profitability and analyst recommendations. Analyst Ratings This is a summary of recent ratings and […]
August 7, 2023
CONMED (NYSE:CNMD – Get Free Report) and Hyperfine (NASDAQ:HYPR – Get Free Report) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their earnings, institutional ownership, valuation, risk, dividends, profitability and analyst recommendations. Institutional & Insider Ownership 13.0% of Hyperfine shares are owned […]
August 5, 2023
Hyperfine (NASDAQ:HYPR – Get Free Report) and Nexalin Technology (NASDAQ:NXL – Get Free Report) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their dividends, institutional ownership, risk, earnings, profitability, analyst recommendations and valuation. Analyst Recommendations This is a breakdown of recent […]